Neuroinflammation has always been of concern in the pathogenesis of Alzheimer’s disease （AD）. As a major inflammatory mediator, prostaglandin E2 （PGE2） plays an important role in the inflammatory process of AD. U...Neuroinflammation has always been of concern in the pathogenesis of Alzheimer’s disease （AD）. As a major inflammatory mediator, prostaglandin E2 （PGE2） plays an important role in the inflammatory process of AD. Up to now, there is still controversy on the neuroprotective or neurotoxic role of PGE2. However, the role of PGE2 in neurodegeneration may be far more complex, due to the 4 EP receptor subtypes. This article aims to summarize the relationship between PGE2 receptor EP subtypes and AD. It is believed that a better understanding of the PGE2 receptor EP subtypes may help to clarify the relation between inflammation and AD, and to develop novel therapeutic strategies targeting specific EP receptor for AD treatment.展开更多
基金supported by grantsfrom the Natural Science Foundation of Zhejiang Province(No. Y206153)the Science and Technology Major Projectsof Zhejiang Province (No. 2007C13053, 2008F80009)the Science and Technology Programme of Hangzhou Munici-pality (No. 20051323B45)
文摘Neuroinflammation has always been of concern in the pathogenesis of Alzheimer’s disease （AD）. As a major inflammatory mediator, prostaglandin E2 （PGE2） plays an important role in the inflammatory process of AD. Up to now, there is still controversy on the neuroprotective or neurotoxic role of PGE2. However, the role of PGE2 in neurodegeneration may be far more complex, due to the 4 EP receptor subtypes. This article aims to summarize the relationship between PGE2 receptor EP subtypes and AD. It is believed that a better understanding of the PGE2 receptor EP subtypes may help to clarify the relation between inflammation and AD, and to develop novel therapeutic strategies targeting specific EP receptor for AD treatment.
